5 unknown. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 5 |
| Phase 1 | 1 | Unknown 1 |
Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome Ruxolitinib - Bronchiolitis Obliterans Syndrome, Hematologic Malignancy | Phase 2 | Unknown | First Affiliated Hospital of Zhejiang University | 50 | 2022-06-01 | 2022-10-19 |
| Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation Allogeneic Hematopoietic Stem Cell Transplantation - Hematologic Malignancy | Phase 1 / Phase 2 | Unknown | Sichuan University | 56 | 2022-03-01 | 2022-03-15 |
| Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT venetoclax combining with fludarabine and melphalan - Hematologic Malignancy, Older Patients | Phase 2 | Unknown | First Affiliated Hospital of Zhejiang University | 50 | 2021-10-07 | 2021-10-27 |
| Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients Azacitidine in Combination With Venetoclax - Hematologic Malignancy, Stem Cell Transplant Complications | Phase 2 | Unknown | First Affiliated Hospital of Zhejiang University | 95 | 2021-03-19 | 2023-02-21 |
| Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients Myeloablative double unit cord blood transplantation - Hematologic Malignancy | Phase 2 | Unknown | Seoul National University Hospital | 39 | 2015-04-01 | 2015-03-11 |
Hematologic Neoplasms (5) · Recurrence (2) · Bronchiolitis Obliterans Syndrome (1)
Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Neoplasms (5) · Neoplasms by Site (5) · Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Graft vs Host Disease (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1)
Azacitidine (1) · Melphalan (1) · fludarabine (1) · ruxolitinib (1) · venetoclax (1)
First Affiliated Hospital of Zhejiang University (3) · Seoul National University Hospital (1) · Sichuan University (1)
China (4)
Yi Luo, M.D. (3) · Jie Ji, MD (1)